Antisecretory agents in gastrointestinal obstruction

Clinics in Geriatric Medicine

Volumn 16, Issue 2, 2000, Pages 327-334

  Muir, J Cameron ^a,b   Von Gunten, Charles F ^c,d  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c San Diego Hospice & Palliative Care Center for Palliative Studies   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPYRRONIUM BROMIDE; OCTREOTIDE; SCOPOLAMINE METHYL BROMIDE; STOMACH SECRETION INHIBITOR;

CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG EFFICACY; HUMAN; INTESTINE OBSTRUCTION; REVIEW; STOMACH OBSTRUCTION; TERMINAL DISEASE; TREATMENT INDICATION;

EID: 0034030210     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0690(05)70059-8     Document Type: Article

References (21)

1. American Hospital Formulary Service Drug Information: Octreotide Acetate 1995 MD, AHFS Bethesda 2609
2. M.J. Baines Nausea, vomiting and intestinal obstruction Fallon M. O'Neill B. 2 ABC of Palliative Care 1998 BMJ Books London 16 18
3. M.J. Baines The pathophysiology and management of malignant intestinal obstruction Doyle D. Hanks G.W.C. MacDonald N. Oxford Textbook of Palliative Medicine 1998 Oxford University Press Oxford 526 534
4. M. Baines D.J. Oliver R.L. Carter Medical management of intestinal obstruction in patients with advanced malignant disease: A clinical and pathological study Lancet 2 1985 990 993
5. G.J. Beattie R. Leonard J.F. Smyth Bowel obstruction in ovarian cancer: Retrospective study and review of the literature Palliat Med 3 1989 275 282
6. J.P. Cello J.H. Grendell P. Basuk Effect of octreotide on refractory AIDS-associated diarrhea Ann Intern Med 115 1991 705 710
7. M.P. Davis A. Furste Glycopyrrolate: A useful drug in the palliation of mechanical bowel obstruction J Pain Symptom Manage 18 1999 153 154
8. De Conno F. L. Saita C. Ripamonti Subcutaneous octreotide in the treatment of pain in advanced cancer patients J Pain Symptom Manage 9 1994 34 38
9. R.L. Fainsinger K. Spachynski J. Hanson Symptom control in terminally ill patients with malignant bowel obstruction J Pain Symptom Manage 9 1994 12 18
10. M.T. Fallon The physiology of somatostatin and its synthetic analog, octreotide European Journal of Palliative Care 1 1994 20 22
11. Lamberts S.W.J. van der Lely A.-J. de Herder W.W. Drug therapy: Octreotide N Engl J Med 334 1996 246 254
12. G. Mangili M. Franchi A. Mariani Octreotide in the management of bowel obstruction in terminal ovarian cancer Gynecol Oncol 61 1996 345 348
13. S. Mercadante Tolerability of continuous subcutaneous octreotide used in combination with other drugs J Pallia Care 11 1995 14 16
14. S. Mercadante S. Maddaloni Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patients J Pain Symptom Manage 7 1992 496 498
15. S. Mercadante E. Spoldi A. Caraceni Octreotide in relieving gastrointestinal symptoms due to bowel obstruction Palliat Med 7 1993 295 299
16. Petrelli N: Octreotide in chemotherapy related diarrhea [abstract 493]. ASCO Proceedings, July 1992
17. J. Riley M.T. Fallon Octreotide in terminal malignant obstruction of the gastrointestinal tract European Journal of Palliative Care 1 1994 23 25
18. C. Ripamonti Bowel Obstruction Berger A. Portenoy R.K. Weissman D.W. Principles and Practice of Supportive Oncology 1998 Lippincott-Raven Pub Philadelphia 207 216
19. P.S. Storey Obstruction of the GI tract American Journal of Hospice and Palliative Care 8 1991 5
20. V. Ventrafridda C. Ripamonti A. Caraceni The management of inoperable gastrointestinal obstruction in terminal cancer patients Tumori 76 1990 389 392
21. C. Ripamonti Malignant bowel obstruction in advanced and terminal cancer patients European Journal of Palliative Care 1 1994 16 19